Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christal D Sohl

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Biochemical Journal|July 31, 2020
An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivityLucas A Luna, Zachary Lesecq, Katharine A White, et al.
Viruses|April 24, 2019
Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem CellsJean A Bernatchez, Michael Coste, Sungjun Beck, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika VirusJean A Bernatchez, Zunhua Yang, Michael Coste, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Catalytically distinct IDH1 mutants tune phenotype severity in tumor modelsMowaffaq Adam Ahmed Adam, Mikella Robinson, Ashley V Schwartz, et al.
The Journal of Biological Chemistry|April 6, 2025
Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor modelsAshley V Schwartz, Grace Chao, Mikella Robinson, et al.
Nature Communications|May 6, 2024
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanismsMatthew Mealka, Nicole A Sierra, Diego Avellaneda Matteo, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanismsMatthew Mealka, Nicole A Sierra, Diego Avellaneda Matteo, et al.
Research Square|March 11, 2024
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanismsMatthew Mealka, Nicole A Sierra, Diego Avellaneda Matteo, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Biochemical Journal|July 31, 2020
An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivityLucas A Luna, Zachary Lesecq, Katharine A White, et al.
Viruses|April 24, 2019
Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem CellsJean A Bernatchez, Michael Coste, Sungjun Beck, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika VirusJean A Bernatchez, Zunhua Yang, Michael Coste, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Catalytically distinct IDH1 mutants tune phenotype severity in tumor modelsMowaffaq Adam Ahmed Adam, Mikella Robinson, Ashley V Schwartz, et al.
The Journal of Biological Chemistry|April 6, 2025
Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor modelsAshley V Schwartz, Grace Chao, Mikella Robinson, et al.
Nature Communications|May 6, 2024
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanismsMatthew Mealka, Nicole A Sierra, Diego Avellaneda Matteo, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanismsMatthew Mealka, Nicole A Sierra, Diego Avellaneda Matteo, et al.
Research Square|March 11, 2024
Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanismsMatthew Mealka, Nicole A Sierra, Diego Avellaneda Matteo, et al.
Pageof 4